Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma (ZOLINZA)
This study is not yet open for participant recruitment.
Verified December 2012 by Samsung Medical Center
Sponsor:
Samsung Medical Center
Information provided by (Responsible Party):
Won Seog Kim, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT01578343
First received: March 30, 2012
Last updated: December 30, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | September 2016 |
| Estimated Primary Completion Date: | March 2015 (Final data collection date for primary outcome measure) |